Adult Human Parvovirus-B19 Infection Presenting with Hearing Difficulty and Dizziness

被引:3
作者
Nara, Masayuki [1 ]
Shirata, Yuko
Kikuchi, Toshiaki [2 ]
Hong, Michio
机构
[1] Tohoku Univ Hosp, Dept Internal Med, Div Comprehens Med, Aoba Ku, Sendai, Miyagi 9808574, Japan
[2] Tohoku Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Sendai, Miyagi 9808574, Japan
关键词
HPV-B19; IgM antibody; immune complex; ear symptoms; erythema infectiosum; B19; INFECTION; MANIFESTATIONS;
D O I
10.1620/tjem.224.57
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Human parvovirus B19 (HPV-B19), a small and non-enveloped DNA virus, causes erythema infectiosum (El) in children. In adults, however, it is known to cause a variety of symptoms. A 39-year-old woman visited our hospital because of low-grade fever, diarrhea, bilateral leg edema, and numbness in the right arm, one and a half months after her daughter developed El. We diagnosed her as HPV-B19 infection after her daughter's history and positive test for serum HPV-B19 IgM antibody, together with the continued observations. Two weeks later, she developed dizziness and left hearing difficulty. However, we did not give her any medication. HPV-B19 IgM antibody value (2.4) measured after one month of the onset was decreased to 1.7, 1.1, and 0.9 after two, three, and five months of the onset, respectively. Thus, it took 5 months for the IgM antibody value to become negative. Her symptoms gradually improved along with the decrease in HPV-B19 antibody without any medication. Hearing difficulty and dizziness are not categorized as manifestations of HPV-B19 infection, because these symptoms are very rare. The present report indicates that the symptoms related to inner ear dysfunctions should be added to those associated with adult HPV-B19 infection. In conclusion, we should consider HPV-B19 infection when we evaluate patients with causeless hearing difficulty and dizziness.
引用
收藏
页码:57 / 59
页数:3
相关论文
共 9 条
[1]   Neurological manifestations of human parvovirus B19 infection [J].
Barah, F ;
Vallely, PJ ;
Cleator, GM ;
Kerr, JR .
REVIEWS IN MEDICAL VIROLOGY, 2003, 13 (03) :185-199
[2]   Clinical aspects of parvovirus B19 infection [J].
Broliden, K. ;
Tolfvenstam, T. ;
Norbeck, O. .
JOURNAL OF INTERNAL MEDICINE, 2006, 260 (04) :285-304
[3]   ERYTHROCYTE-P ANTIGEN - CELLULAR RECEPTOR FOR B19 PARVOVIRUS [J].
BROWN, KE ;
ANDERSON, SM ;
YOUNG, NS .
SCIENCE, 1993, 262 (5130) :114-117
[4]   MULTIPLE GLYCOSPHINGOLIPIDS DETERMINE THE TISSUE TROPISM OF PARVOVIRUS B19 [J].
COOLING, LLW ;
KOERNER, TAW ;
NAIDES, SJ .
JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (05) :1198-1205
[5]  
COTTER CS, 1994, LARYNGOSCOPE, V104, P1235
[6]   A clinical study of adult human parvovirus B19 infection [J].
Hayakawa, H ;
Tara, M ;
Niina, K ;
Osame, M .
INTERNAL MEDICINE, 2002, 41 (04) :295-299
[7]  
Kerr JR, 2002, J RHEUMATOL, V29, P595
[8]   Slow clearance of human parvovirus B19 viremia following acute infection [J].
Lindblom, A ;
Isa, A ;
Norbeck, O ;
Wolf, S ;
Johansson, B ;
Broliden, K ;
Tolfvenstam, T .
CLINICAL INFECTIOUS DISEASES, 2005, 41 (08) :1201-1203
[9]   CLINICAL MANIFESTATIONS OF HUMAN PARVOVIRUS-B19 IN ADULTS [J].
WOOLF, AD ;
CAMPION, GV ;
CHISHICK, A ;
WISE, S ;
COHEN, BJ ;
KLOUDA, PT ;
CAUL, O ;
DIEPPE, PA .
ARCHIVES OF INTERNAL MEDICINE, 1989, 149 (05) :1153-1156